BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2699323)

  • 1. Role of vitamin E as nitrite scavenger and N-nitrosamine inhibitor: a review.
    Lathia D; Blum A
    Int J Vitam Nutr Res; 1989; 59(4):430-8. PubMed ID: 2699323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-tocopherol: uses in preventing nitrosamine formation.
    Mergens WJ; Kamm JJ; Newmark HL; Fiddler W; Pensabene J
    IARC Sci Publ (1971); 1978; (19):199-212. PubMed ID: 28277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of ascorbic acid and DL-alpha-tocopherol on the formation of nitrosamines in an in vitro gastrointestinal model system.
    Mergens WJ; Chau J; Newmark HL
    IARC Sci Publ; 1980; (31):259-69. PubMed ID: 7228256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Model system studies on N-nitrosamine formation in relation to cured meat: the non-polar phase and S-nitroso peptides.
    Massey RC; Dennis MJ; Crews C; Davies R; McWeeny DJ
    IARC Sci Publ; 1980; (31):291-303. PubMed ID: 7228259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Influence of microorganisms on the formation of nitrosamines].
    Klein D; Lafont P; Keshawarz A
    Ann Nutr Aliment; 1978; 32(2-3):425-35. PubMed ID: 707923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Abnormal effect of nitrosation inhibitors in human gastric juice].
    Ermilov VB; Shendrikova IA; Volkov DP; Stefanenko IuF; Chernomordikov VG
    Vopr Onkol; 1986; 32(10):58-64. PubMed ID: 3776128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of volatile nitrosamines in human feces.
    Lee L; Archer MC; Bruce WR
    Cancer Res; 1981 Oct; 41(10):3992-4. PubMed ID: 7285009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiological assessment of risk to humans from exposure to nitrosamines.
    Miller AB; Choi BC; Howe GR; Burch JD; Sherman GJ
    IARC Sci Publ; 1984; (57):929-36. PubMed ID: 6533077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug interactions. II. Formation of nitrosamines from therapeutic drugs. Properties and kinetics of the formation of N-nitrosopropranolol from nitrite and the secondary amine propranolol hydrochloride.
    Chen J; Raisfeld-Danse IH
    J Pharmacol Exp Ther; 1983 Jun; 225(3):705-12. PubMed ID: 6864529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the intake of selected vitamins and minerals on cancer prevention.
    Birt DF
    Magnesium; 1989; 8(1):17-30. PubMed ID: 2661927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin C, vitamin E and cancer (review).
    Chen LH; Boissonneault GA; Glauert HP
    Anticancer Res; 1988; 8(4):739-48. PubMed ID: 3052251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ester-mediated nitrosamine formation from nitrite and secondary or tertiary amines.
    Loeppky RN; Tomasik W; Millard TG
    IARC Sci Publ; 1984; (57):353-63. PubMed ID: 6533026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formation of N-nitrosamine and N-nitrosamino acids from food products and nitrite under simulated gastric conditions.
    Groenen PJ; de Cock-Bethbeder MW; Bouwman J; Dhont JH
    IARC Sci Publ; 1980; (31):215-29. PubMed ID: 7228254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective role of Vitamin E pre-treatment on N-nitrosodiethylamine induced oxidative stress in rat liver.
    Bansal AK; Bansal M; Soni G; Bhatnagar D
    Chem Biol Interact; 2005 Oct; 156(2-3):101-11. PubMed ID: 16144695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental model for evaluating animal exposure to endogenous N-nitrosodi-n-butylamine by measuring its urinary metabolites N-butyl-N-(4-hydroxybutyl)-nitrosamine and N-butyl-N-(3-carboxypropyl)nitrosamine.
    Airoldi L; Spagone C; Macri A; Fanelli R
    IARC Sci Publ; 1984; (57):237-40. PubMed ID: 6533013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-nitrosamine Mitigation with Nitrite Scavengers in Oral Pharmaceutical Drug Products.
    Bayne AV; Misic Z; Stemmler RT; Wittner M; Frerichs M; Bird JK; Besheer A
    J Pharm Sci; 2023 Jul; 112(7):1794-1800. PubMed ID: 37023856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological actions and possible uses of vitamin E.
    Galli C; Socini A
    Acta Vitaminol Enzymol; 1982; 4(3):245-51. PubMed ID: 6756099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effect of vitamin E on proinflammatory cytokines-and endotoxin-induced nitric oxide release in alveolar macrophages.
    Khanduja KL; Avti PK; Kumar S; Pathania V; Pathak CM
    Life Sci; 2005 Apr; 76(23):2669-80. PubMed ID: 15792834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tobacco, Microbes, and Carcinogens: Correlation Between Tobacco Cure Conditions, Tobacco-Specific Nitrosamine Content, and Cured Leaf Microbial Community.
    Law AD; Fisher C; Jack A; Moe LA
    Microb Ecol; 2016 Jul; 72(1):120-129. PubMed ID: 27023797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of N-nitroso compounds (NOC) and N-nitrosation in etiology of gastric, esophageal, nasopharyngeal and bladder cancer and contribution to cancer of known exposures to NOC.
    Mirvish SS
    Cancer Lett; 1995 Jun; 93(1):17-48. PubMed ID: 7600541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.